Safe and Effective Vaccine That Prevents Many Kinds of Cancer Continues to Be Underused
The number of girls and boys aged 13 to 17 years receiving human papillomavirus (HPV) vaccine remains unacceptably low despite a slight increase in vaccination coverage since 2012.